A new outreach video highlights the objectives of the IMVACS project and the contribution of European-African scientific collaboration to the development of innovative strategies for preventing malaria among children.

Malaria continues to represent one of the major public health challenges in sub-Saharan Africa, particularly among children under 5. The introduction of new malaria vaccines offers important opportunities to strengthen prevention strategies, especially in areas where malaria transmission is highly seasonal.

In this context, IMVACS is our EDCTP3-funded project conducted in Burkina Faso and Mali which evaluates the integration of the R21/Matrix-M malaria vaccine into seasonal malaria chemoprevention (SMC) campaigns, compared with vaccination delivered through routine immunisation services (EPI). 

Its main objective is to generate scientific evidence on vaccination coverage, feasibility, acceptability, costs, and cost-effectiveness of this approach, helping to inform future malaria prevention policies and practices.

Communication and Dissemination: what’s beyond a video

As the consortium coordinator, R-Evolution Worldwide plays a central role in the overall management and coordination of project activities, facilitating collaboration among the European and African scientific institutions involved in the study.

Alongside our coordination responsibilities, we lead activities related to communication, dissemination, and translation of research findings into policy: its commitment helps strengthen dialogue among researchers, health authorities, and other relevant stakeholders, supporting the translation of evidence generated by IMVACS into prevention strategies adapted to the needs and priorities of the participating countries.

As part of the project’s communication and dissemination activities, a new video offers an opportunity to promote the contributions of African research partners, who are directly responsible for conducting the study in the field – in Burkina Faso, research activities are carried out in the Boussé health district by CNRST/IRSS; in Mali, the study is conducted by USTTB in the Dioïla health district.

In the video Dr Halidou Tinto (CNRST/IRSS)and Sara Greco (Phd student at UniSalento and Scientific Project Coordinator at R-EvoWW) explain how IMVACS’ research activities are exploring new opportunities to improve malaria prevention among children.
Using simple, accessible language and examples drawn from everyday life, their conversation brings the people and stories behind IMVACS closer to the public, making scientific research and institutional cooperation easier to understand and more relevant to people’s direct experiences.

Watch the full video to discover how IMVACS is contributing to malaria prevention research in Burkina Faso and Mali: Watch the IMVACS video

The IMVACS project (Grant Agreement No. 101160339) is funded by the Global Health EDCTP3 Joint Undertaking under the European Union’s Horizon Europe programme.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

World Tuberculosis Day – March 24, 2026

Tuberculosis (TB) remains one of the leading infectious diseases worldwide. According to the WHO Global Tuberculosis Report, in 2023 an estimated 10.8 million people developed TB globally, and about 1.25

Workshop: Ethics review preparedness during COVID-19

Glad to be among the speakers https://bit.ly/3er42gC

INTEGRATION Annual Project Meeting Y3

The INTEGRATION consortium held its annual meeting of the third year of the project on 21st and 22nd March 2024 in Paris. The INTEGRATION project involves the University of Sciences, Techniques